Baseline pathogenic mutations in non-AR/non-TP53 genes and prediction of response to high-dose testosterone.

146Background: The fact that high dose of testosterone (HDT) elicits positive responses in a subset of prostate cancer patients (pts) is surprising and puzzling. Genomics data differentiating respo...